MUZAFAR H SURAHIO
Allopathic & Osteopathic Physicians|Internal Medicine STATEN ISLAND, NY NPI 1932141017
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$967.00
- Category: General Payments
- Program years: PY2019–2024
- Record count: 41
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $174.95 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $174.95 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $45.70 | 2 |
| Merck Sharp & Dohme Corporation | $39.81 | 2 |
| PFIZER INC. | $37.76 | 2 |
| Neurocrine BioSciences, Inc. | $26.70 | 1 |
| Janssen Biotech, Inc. | $24.98 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078471120 | Janssen Biotech, Inc. | $24.98 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104560472 | AstraZeneca Pharmaceuticals LP | $22.46 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104580878 | AstraZeneca Pharmaceuticals LP | $23.24 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131312845 | PFIZER INC. | $18.86 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131968479 | PFIZER INC. | $18.90 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141633879 | Merck Sharp & Dohme LLC | $26.37 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141920588 | Merck Sharp & Dohme LLC | $13.44 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150834668 | Neurocrine Biosciences, Inc. | $26.70 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.